SGNT
RhumbLine Advisers’s SAGENT PHARMACEUTICALS INC COM STK (DE) SGNT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q3 | – | Sell |
-34,293
| Closed | -$514K | – | 2976 |
|
|
2016
Q2 | $514K | Buy |
34,293
+7,268
| +27% | +$109K | ﹤0.01% | 2179 |
|
|
2016
Q1 | $329K | Buy |
27,025
+660
| +3% | +$8.04K | ﹤0.01% | 2484 |
|
|
2015
Q4 | $419K | Buy |
26,365
+2,820
| +12% | +$44.8K | ﹤0.01% | 2361 |
|
|
2015
Q3 | $361K | Buy |
23,545
+936
| +4% | +$14.4K | ﹤0.01% | 2436 |
|
|
2015
Q2 | $550K | Sell |
22,609
-2,365
| -9% | -$57.5K | ﹤0.01% | 2262 |
|
|
2015
Q1 | $581K | Buy |
24,974
+3,050
| +14% | +$71K | ﹤0.01% | 2208 |
|
|
2014
Q4 | $551K | Sell |
21,924
-125
| -0.6% | -$3.14K | ﹤0.01% | 2218 |
|
|
2014
Q3 | $686K | Buy |
22,049
+250
| +1% | +$7.78K | ﹤0.01% | 2017 |
|
|
2014
Q2 | $564K | Buy |
21,799
+8,018
| +58% | +$207K | ﹤0.01% | 2196 |
|
|
2014
Q1 | $322K | Sell |
13,781
-810
| -6% | -$18.9K | ﹤0.01% | 2498 |
|
|
2013
Q4 | $370K | Buy |
14,591
+100
| +0.7% | +$2.54K | ﹤0.01% | 2439 |
|
|
2013
Q3 | $296K | Sell |
14,491
-143
| -1% | -$2.92K | ﹤0.01% | 2533 |
|
|
2013
Q2 | $307K | Buy |
+14,634
| New | +$307K | ﹤0.01% | 2622 |
|